BlackRock reports 6.51M shares (13.1%) of STAAR SURGICAL

BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 6,507,911 shares of STAAR SURGICAL CO common stock, representing 13.1% of the class as of 03/31/2026.

Rhea-AI Filing Summary

BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 6,507,911 shares of STAAR SURGICAL CO common stock, representing 13.1% of the class as of 03/31/2026.

The filing attributes 6,453,653 shares of sole voting power and lists iShares Core S&P Small-Cap ETF as a holder with more than 5% interest in the issuer’s common stock. The amendment is signed by a Managing Director on 04/24/2026.

Insights

Institutional Ownership Analyst

BlackRock reports a large passive stake in STAAR SURGICAL CO (13.1% of common stock).

The Schedule 13G/A shows 6,507,911 shares beneficially owned with 6,453,653 shares of sole voting power as of 03/31/2026. This filing is consistent with passive institutional disclosure rather than an active acquisition schedule.

Watch subsequent filings for any change to a Schedule 13D or material changes in voting power; timing of such disclosures would be in later SEC submissions.

Corporate Governance Specialist

The amendment clarifies voting and dispositive powers across BlackRock business units.

The cover notes securities are aggregated across Reporting Business Units of BlackRock, Inc., per SEC Release No. 34-39538. The filing also identifies an underlying holder, iShares Core S&P Small-Cap ETF, with >5% interest.

Governance implications depend on whether voting remains unified; subsequent filings could detail any subsidiary classification referenced in Exhibit 99.

Key Figures

Beneficial ownership: 6,507,911 shares Percent of class: 13.1% Sole voting power: 6,453,653 shares +3 more

6 metrics

Beneficial ownership 6,507,911 shares Amount beneficially owned as of 03/31/2026

Percent of class 13.1% Percent of common stock represented by 6,507,911 shares

Sole voting power 6,453,653 shares Sole power to vote reported in Item 4(c)(i)

Sole dispositive power 6,507,911 shares Sole power to dispose reported in Item 4(c)(iii)

CUSIP 852312305 CUSIP for STAAR SURGICAL CO common stock

Signature date 04/24/2026 Date amendment was signed by Managing Director

Key Terms

Schedule 13G/A, Beneficial ownership, Sole dispositive power, Reporting Business Units

4 terms

Schedule 13G/A regulatory

"amendment to Schedule 13G reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Amount beneficially owned: 6507911"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 6507911"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Reporting Business Units regulatory

"securities beneficially owned by certain business units (collectively, the "Reporting Business Units")"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many STAAR SURGICAL CO (STAA) shares does BlackRock report owning?

BlackRock reports beneficial ownership of 6,507,911 shares of STAAR SURGICAL CO common stock. The filing states this equals 13.1% of the class as of 03/31/2026.

What voting and dispositive powers does BlackRock report for STAA?

BlackRock reports 6,453,653 shares of sole voting power and 6,507,911 shares of sole dispositive power. Shared voting and dispositive power are reported as 0 in the amendment.

Does the filing identify other holders related to BlackRock's position in STAA?

Yes; the amendment states iShares Core S&P Small-Cap ETF has an interest exceeding 5% of STAAR SURGICAL CO common stock. The filing notes aggregation across Reporting Business Units.

What is the filing date and who signed the amendment for BlackRock?

The cover shows the reporting period date 03/31/2026 and the amendment is signed by Spencer Fleming, Managing Director, on 04/24/2026.

Why is the filing an amendment (13G/A) rather than a 13D?

The amendment is a Schedule 13G/A disclosure used by passive institutional investors. The filing aggregates holdings of BlackRock Reporting Business Units per SEC Release No. 34-39538; it does not state active intent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 04:11 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 19)

STAAR SURGICAL CO

(Name of Issuer)

Common Stock

(Title of Class of Securities)

852312305

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 852312305

1

Names of Reporting Persons

BlackRock, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 6,453,653.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,507,911.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,507,911.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.1 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: STAAR SURGICAL CO
(b)	Address of issuer's principal executive offices: 25510 Commercentre Drive Lake Forest CA 92630
Item 2.
(a)	Name of person filing: BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 852312305
Item 4.	Ownership
(a)	Amount beneficially owned: 6507911
(b)	Percent of class: 13.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 6453653
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 6507911
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of STAAR SURGICAL CO is more than five percent of the total outstanding common stock.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock, Inc.

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	04/24/2026

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7